Resistin

Source: Wikipedia, the free encyclopedia.
RETN
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_020415
NM_001193374
NM_001385725
NM_001385726
NM_001385727

NM_001204959
NM_022984

RefSeq (protein)

NP_001180303
NP_065148

NP_001191888
NP_075360

Location (UCSC)Chr 19: 7.67 – 7.67 MbChr 8: 3.71 – 3.71 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Resistin also known as adipose tissue-specific secretory factor (ADSF) or C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein (XCP1) is a cysteine-rich peptide hormone derived from adipose tissue that in humans is encoded by the RETN gene.[5]

In

T2DM).[6]

Discovery

Resistin was discovered in 2001 by the group of Dr

endocrine functions likely involved in insulin resistance
.

This idea primarily stems from studies demonstrating that

mice).[7][8][9][10][11] Since these observations, further research has linked resistin to other physiological systems such as inflammation and energy homeostasis.[12][13][14]

This article discusses the current research proposing to link resistin to inflammation and energy homeostasis, including its alleged role in insulin resistance in obese subjects, a subject reviewed by Vidal-Puig and O'Rahilly in 2001,[15] and by M.A. Lazar in 2007.[16]

Inflammation

Inflammation is the first

cytokines. As cited, it has recently been discovered that resistin also participates in the inflammatory response.[17][18][19][20]

In further support of its inflammatory profile, resistin has been shown to increase transcriptional events, leading to an increased expression of several pro-inflammatory cytokines including (but not limited to)

microbial antigens such as lipopolysaccharide,[24] which are recognized by leukocytes. Taken together, because resistin is reputed to contribute to insulin resistance, results such as those mentioned suggest that resistin may be a link in the well-known association between inflammation and insulin resistance.[25]

In accordance, it is expected that, if resistin does serve as a link between obesity and T2DM while at the same time contributing to the inflammatory response, then proportional increases in

diseases
with or without associated insulin resistance.

This adipokine is associated with markers of inflammation in seminal plasma and the concentrations of seminal resistin correlate positively with those of proinflammatory mediators such as interleukin-6 (IL-6), elastase and tumor necrosis factor-α (TNF-α). During inflammation, the concentrations of cytokines and ROS increase, and this may have a deleterious effect on the male reproductive function.[29] One study showed that there was a negative correlation between the concentrations of seminal resistin and spermatic motility and vitality. (The seminal concentrations of resistin were significantly higher in cases of leukocyte spermia or if the patients were smokers.)[30]

Obesity and insulin resistance

Arguments for

Much of what is

central obesity (waistline adipose tissue) is the region of adipose tissue that contributes most to rising levels of serum resistin.[34] This is significant, considering the link between central obesity and insulin resistance, two marked peculiarities of T2DM.[9][35]

Although resistin levels increase with obesity, it is questioned whether this increase is responsible for the insulin resistance associated with increased adiposity.[citation needed] Several reports have shown a positive correlation between resistin levels and insulin resistance.[36][37][38][39] This is supported by reports of correlation between resistin levels and subjects with T2DM.[7][31][40][41] If resistin contributes to the pathogenesis of insulin resistance in T2DM, then designing drugs to promote decreased serum resistin in T2DM subjects may deliver therapeutic benefits.[42]

Resistin can increase levels of circulating

arteries, increasing risk of heart disease has an adverse impact on the efficacy of statins, the primary drug used to reduce cholesterol in fighting of cardiovascular disease.[43]
In the liver, resistin increases LDL production and degrades LDL receptors, impairing the ability to process LDL.

Arguments against

The amount of evidence supporting the resistin link theory between obesity and T2DM is vast.[citation needed] Nevertheless, this theory lacks support from the entire scientific community, as a number of studies present evidence against it.[44][45][46] Such studies have found significantly decreased serum concentrations of resistin with increased adiposity,[47][48][49] suggesting not only that resistin is downregulated in obese subjects, but also that decreased resistin levels may contribute to the links between obesity and T2DM. Data contradicting the idea that weight loss coincides with decreased serum resistin concentrations have also been presented; such studies instead report that weight loss is associated with marked increases in serum resistin.[21] The idea that resistin links obesity to T2DM is under scrutiny, reports have been made of ubiquitous resistin expression in many tissues, rather than only those characteristic of obesity, such as adipocytes [citation needed].

Although nearly as many scientists oppose the theory as those who support it [

energy homeostasis, while also demonstrating properties that help to incite inflammatory responses to sites of infection
.

Structure

Crystal structures of resistin reveal an unusual composition of several subunits that are held together by

disulfide linkages
mediate the formation of tail-to-tail hexamers. The globular domain from resistin contains five disulfide bonds (Cys35-Cys88, Cys47-Cys87, Cys56-Cys73, Cys58-Cys75, and Cys62-Cys77). This suggests that the disulfide pattern will be conserved.

The interchain disulfide bonds of resistin and resistin-like molecule β (RELMß) are novel in that they are highly solvent when exposed, ranging from 84.6% to 89.5%. An average solvent exposure for all disulfide bonds is 9.9%, and 16.7% for 1,209 interchain disulfide bonds. Therefore, the most highly uncovered disulfide bonds found for intact proteins are resistin's disulfides in high-resolution.

A Cys6Ser resistin mutant was substantially more potent at the low concentration and had a greater effect than the wild-type resistin at the high concentration. This result suggests that processing of the intertrimer disulfide bonds may reflect a mandatory step toward activation. Other results also suggest that both the Cys6Ser-mutant and wild-type resistin target mainly the liver.

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000104918Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000012705Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. PMID 12050208
    .
  6. .
  7. ^ .
  8. ^ .
  9. ^ .
  10. .
  11. .
  12. .
  13. .
  14. ^ .
  15. .
  16. .
  17. .
  18. .
  19. .
  20. .
  21. ^ .
  22. .
  23. .
  24. .
  25. .
  26. .
  27. .
  28. .
  29. .
  30. .
  31. ^ .
  32. .
  33. .
  34. .
  35. .
  36. .
  37. .
  38. .
  39. .
  40. .
  41. .
  42. .
  43. ^ "Canadian scientists discover cause of high cholesterol". Science Codex. October 28, 2012.
  44. PMID 12507502
    .
  45. .
  46. .
  47. .
  48. .
  49. .

External links